Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115269) titled 'Study on the efficacy of Utidelone combined with Anotinib in the treatment of advanced Non-Small Cell Lung Cancer' on Dec. 24, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Condition:
Third-line advanced non-small cell lung cancer (NSCLC) after prior treatment failure
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-01-01
Target Sample Size: Intervention Group:61;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=2...